Last reviewed · How we verify
NCT06573476
Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and mHealth Platform
NA trial testing PRC supported text + AI driven CSDH-enhanced text in Opioid Use Disorder in 180 participants. Currently enrolling.
15 September 2025
Quick facts
| Lead sponsor | Friends Research Institute, Inc. |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 180 |
| Start date | 25 June 2025 |
| Primary completion | 15 September 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- PRC supported text + AI driven CSDH-enhanced text
- AI driven CSDH-enhanced text only
- Treatment as Usual (TAU) — full drug profile →
Conditions studied
- Opioid Use Disorder — all drugs for Opioid Use Disorder →
Sponsor
Friends Research Institute, Inc.
Who can join
Adults 18 to 99, any sex, with Opioid Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to adapt an existing Cultural Structural Humility (CSH) training into a video format for peer recovery coaches (PRCs) and refine an AI-driven texting tool to reinforce the training. After refining these tools using user-centered design, a pilot test will be conducted to assess their impact on the uptake of opioid treatment and social services. The study will also evaluate the feasibility and effectiveness of the intervention to inform future large-scale trials.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06573476
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Opioid Use Disorder
Currently open trials in the same condition.
- NCT07278518 — Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine · NA · recruiting
- NCT07044466 — Social Functioning in Opioid Use Disorder · NA · recruiting
- NCT07158853 — Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder · NA · recruiting
- NCT06943859 — Ketamine for Opioid Use Disorder · Phase 2 · recruiting
- NCT06651177 — Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder · Phase 2 · recruiting
Other Friends Research Institute, Inc. trials
Trials by the same sponsor.
- NCT07262190 — NavSTAR Implementation Effectiveness Trial Across a Health System · NA · recruiting
- NCT06306443 — Buprenorphine for Individuals in Jail · Phase 3 · recruiting
- NCT07524738 — Telemedicine XR-B for Individuals in Jail · Phase 3 · active not recruiting
- NCT06569667 — Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids · NA · recruiting
- NCT06634277 — Philly NavSTAR Implementation Trial · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06573476 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Friends Research Institute, Inc.
- Last refreshed: 7 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06573476.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing